Castle Creek Pharmaceutical Holdings to Acquire Fibrocell

    NEXT STORY
    SpringWorks Therapeutics Announces Pricing Of Initial Public Offering
    PREV STORY
    Ascendis Pharma A/S Announces Presentations on Achondroplasia and TransCon™ CNP at International Skeletal Dysplasia Society Meeting
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Intra-Cellular Therapies Announces Presentations on Lumateperone at Two Upcoming Medical Conferences

    NEW YORK, May 04, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    ContraFect Announces Appointment of Lishan Aklog, M.D. to Board of Directors

    author_avatar
    NASDAQ Market News

    Advancements in the Treatment of Myelodysplastic Syndromes and RAS-Mutated Lung Cancers to be Presented by Key Opinion Leaders on Thursday, February 7, 2019, in New York City

    Invitation-only breakfast event sponsored by Onconova Therapeutics will also be webcast, beginning at 8:00 ...

    author_avatar
    NASDAQ Market News